Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Chris, Recknor"'
Autor:
Lorenz C Hofbauer, ProfMD, Richard Witvrouw, MD, Zsuzsanna Varga, MD, Naofumi Shiota, MD, Malika Cremer, PharmD, Laszlo B Tanko, MD, Daniel Rooks, PhD, Lixin Zhang Auberson, MD, Michal Arkuszewski, MD, Nathalie Fretault, MSc, Agnes Annette Schubert-Tennigkeit, MD, Dimitris A Papanicolaou, MD, Chris Recknor, MD
Publikováno v:
The Lancet. Healthy Longevity, Vol 2, Iss 5, Pp e263-e274 (2021)
Summary: Background: Older adult patients (ie, those aged ≥60 years) undergoing surgery for hip fracture repair frequently experience loss of muscle mass and strength due to poor mobility and delayed functional recovery. No proven treatment is curr
Externí odkaz:
https://doaj.org/article/3cead3b30953497886dc0746cff88602
Autor:
Jacques P. Brown, Arkadi Chines, Roland Chapurlat, Joseph Foldes, Xavier Nogues, Roberto Civitelli, Tobias De Villiers, Fabio Massari, Cristiano Zerbini, Wenjing Yang, Chris Recknor, Cesar Libanati
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100326- (2020)
Externí odkaz:
https://doaj.org/article/add936b43c104d41b4f663e528e03a5d
Autor:
Jonathan D. Adachi, Henry G. Bone, Nadia S. Daizadeh, Paula Dakin, Socrates Papapoulos, Peyman Hadji, Chris Recknor, Michael A. Bolognese, Andrea Wang, Celia J. F. Lin, Rachel B. Wagman, Serge Ferrari
Publikováno v:
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-8 (2017)
Abstract Background Denosumab treatment for up to 8 years in the FREEDOM study and Extension was associated with low fracture incidence. It was not clear whether subjects who discontinued during the study conduct had a higher risk of fracture than th
Externí odkaz:
https://doaj.org/article/82d84359d66240d5b137491968ed5b27
Autor:
null Edward Czerwinski, null Jose Cardona, null Rafal Plebanski, null Chris Recknor, null Tamara Vokes, null Kenneth G. Saag, null Neil Binkley, null E. Michael Lewiecki, null Jonathan Adachi, null Dorota Knychas, null David Kendler, null Eric Orwoll, null Yinzhong Chen, null Leny Pearman, null Y. Heather Li, null Bruce Mitlak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c24c9f5a40de4499c4d6f86a643b8dd
https://doi.org/10.1002/jbmr.4719/v2/response1
https://doi.org/10.1002/jbmr.4719/v2/response1
Autor:
Edward Czerwinski, Jose Cardona, Rafal Plebanski, Chris Recknor, Tamara Vokes, Kenneth G Saag, Neil Binkley, E Michael Lewiecki, Jonathan Adachi, Dorota Knychas, David Kendler, Eric Orwoll, Yinzhong Chen, Leny Pearman, Y Heather Li, Bruce Mitlak
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchReferences. 37(12)
Abaloparatide significantly increased bone mineral density (BMD) in women with postmenopausal osteoporosis and decreased risk of vertebral, nonvertebral, and clinical fractures compared with placebo. The Abaloparatide for the Treatment of Men with Os
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17070371ee42bf7cc267ca1661f59f2b
https://pubmed.ncbi.nlm.nih.gov/36190391
https://pubmed.ncbi.nlm.nih.gov/36190391
Autor:
Benjamin Z. Leder, Paul D. Miller, Chris Recknor, Hua Zhou, David W. Dempster, Bruce H. Mitlak, Sudhaker D Rao, Miriam Annett, Michael S. Ominsky
Publikováno v:
Journal of Bone and Mineral Research
Anabolic osteoporosis drugs improve bone mineral density by increasing bone formation. The objective of this study was to evaluate the early effects of abaloparatide on indices of bone formation and to assess the effect of abaloparatide on modeling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2ccf0ef31c3c408522f5bfbe229e970
http://europepmc.org/articles/PMC8248188
http://europepmc.org/articles/PMC8248188
Autor:
Edward Czerwinski, Jose Cardona, Rafal Plebanski, Chris Recknor, Tamara Vokes, Kenneth Saag, Neil Binkley, E. Michael Lewiecki, Jonathan Adachi, Dorota Knychas, David Kendler, Eric Orwoll, Yinzhong Chen, Leny Pearman, Y. Heather Li
Publikováno v:
Endocrine Practice. 28:S78-S79
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::834c514b81a85a4cde2578ef1d09b182
https://doi.org/10.1016/j.eprac.2022.03.191
https://doi.org/10.1016/j.eprac.2022.03.191
Autor:
Michael Mcclung, Paul Miller, Chris Recknor, Peter Mesenbrink, Christina Bucci-Rechtweg, Claude-Laurent Benhamou
Publikováno v:
Остеопороз и остеопатии, Vol 14, Iss 2, Pp 37-39 (2011)
Профилактика остеопоротических переломов, особенно бедренной кости и позвонков, - это важная проблема здравоохранения. Подобные перело
Externí odkaz:
https://doaj.org/article/8bbde3e3ba2842ffa8882eb259f3f6f9
Autor:
David W. Dempster, Benjamin Z. Leder, Bruce H. Mitlak, Hua Zhou, Paul D. Miller, Sudhaker D Rao, Miriam Annett, Chris Recknor, Michael S. Ominsky
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::239cb039e8949517868e32af0fd66f76
https://doi.org/10.1002/jbmr.4243/v2/response1
https://doi.org/10.1002/jbmr.4243/v2/response1
Autor:
Lorenz C Hofbauer, Agnes Annette Schubert-Tennigkeit, Michal Arkuszewski, Richard Witvrouw, Nathalie Fretault, Chris Recknor, Malika Cremer, Daniel Rooks, Lixin Zhang Auberson, Zsuzsanna Varga, Dimitris Papanicolaou, Laszlo B Tanko, Naofumi Shiota
Publikováno v:
The Lancet. Healthy Longevity, Vol 2, Iss 5, Pp e263-e274 (2021)
Summary: Background: Older adult patients (ie, those aged ≥60 years) undergoing surgery for hip fracture repair frequently experience loss of muscle mass and strength due to poor mobility and delayed functional recovery. No proven treatment is curr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55db63a8a0520d098c3571f99570364a
https://pubmed.ncbi.nlm.nih.gov/36098123
https://pubmed.ncbi.nlm.nih.gov/36098123